{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-007383","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2025-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.173420+00:00","generated_at":"2026-05-24T21:45:11.638744+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Apyx Medical Q4 2024 revenue $14.2M (down 3% YoY); net loss narrows to $4.6M; submits AYON 510(k) ahead of schedule","bullets":["Q4 total revenue $14.2M (-3% YoY); Advanced Energy flat at $12.1M. Full year revenue $48.1M (-8%).","Net loss Q4 $4.6M ($0.12 per share) vs $9.6M loss in Q4 2023; adjusted EBITDA loss $2.2M vs $4.7M.","Full year 2024 net loss $23.5M ($0.66 per share) vs $18.7M; adjusted EBITDA loss $14.3M vs $13.4M.","Submitted 510(k) for AYON Body Contouring System ~90 days early; planned launch back half 2025 pending clearance.","Cost restructuring: workforce reduced ~25%, annual savings ~$4.3M. 2025 guidance: revenue $47.6-49.0M, opEx <$40M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-007383","json":"https://secwatch.observer/filing/0001437749-25-007383.json","markdown":"https://secwatch.observer/filing/0001437749-25-007383.md","text":"https://secwatch.observer/filing/0001437749-25-007383.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000143774925007383/0001437749-25-007383-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000143774925007383/apyx20241230_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T21:45:11.638744+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}